MA30598B1 - Composition pharmaceutique contenant un acide tetrahydrofolique. - Google Patents
Composition pharmaceutique contenant un acide tetrahydrofolique.Info
- Publication number
- MA30598B1 MA30598B1 MA31584A MA31584A MA30598B1 MA 30598 B1 MA30598 B1 MA 30598B1 MA 31584 A MA31584 A MA 31584A MA 31584 A MA31584 A MA 31584A MA 30598 B1 MA30598 B1 MA 30598B1
- Authority
- MA
- Morocco
- Prior art keywords
- tetrahydrofolic acid
- pharmaceutical composition
- composition containing
- progestagen
- estrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
La présente invention concerne des compositions pharmaceutiques solides, en particulier des contraceptifs oraux, comprenant un progestagène, telle que la drospirénone; un oestrogène, tel que l'éthinyloestradiol; un acide tétrahydrofolique ou sel pharmaceutiquement acceptable de celui-ci, tel que le 5-méthyl-(6S)- tétrahydrofolate de calcium; et au moins un excipient ou support pharmaceutiquement acceptable. Les compositions de l'invention confèrent une bonne stabilité de l'acide tétrahydrofolique au stockage tout en garantissant encore une libération rapide et fiable de l'¿strogène et du progestagène présents dans la composition.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06014002 | 2006-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30598B1 true MA30598B1 (fr) | 2009-07-01 |
Family
ID=36763829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31584A MA30598B1 (fr) | 2006-07-06 | 2009-01-23 | Composition pharmaceutique contenant un acide tetrahydrofolique. |
Country Status (32)
Country | Link |
---|---|
EP (2) | EP2422774B1 (fr) |
JP (1) | JP2009542591A (fr) |
KR (2) | KR20090033889A (fr) |
CN (3) | CN101489563A (fr) |
AR (2) | AR061958A1 (fr) |
AU (1) | AU2007271449B2 (fr) |
BR (1) | BRPI0713565B8 (fr) |
CA (2) | CA2656131C (fr) |
CL (1) | CL2007001962A1 (fr) |
CO (1) | CO6150125A2 (fr) |
CR (1) | CR10549A (fr) |
CU (1) | CU20090004A7 (fr) |
EC (1) | ECSP099030A (fr) |
ES (1) | ES2626838T5 (fr) |
GT (1) | GT200900001A (fr) |
HK (1) | HK1131917A1 (fr) |
IL (3) | IL196027A0 (fr) |
MA (1) | MA30598B1 (fr) |
MX (1) | MX2009000079A (fr) |
MY (1) | MY169516A (fr) |
NO (1) | NO347567B1 (fr) |
NZ (1) | NZ573766A (fr) |
PE (3) | PE20150287A1 (fr) |
PH (1) | PH12012501774B1 (fr) |
RU (2) | RU2479306C2 (fr) |
SG (1) | SG188869A1 (fr) |
TN (1) | TNSN08543A1 (fr) |
TW (2) | TWI508730B (fr) |
UA (2) | UA105078C2 (fr) |
UY (1) | UY30462A1 (fr) |
WO (1) | WO2008003432A1 (fr) |
ZA (4) | ZA200900868B (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
CN101489563A (zh) | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
US20100317635A1 (en) * | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
UY32836A (es) * | 2009-08-12 | 2011-03-31 | Bayer Schering Pharma Ag | Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato |
EA026095B1 (ru) * | 2010-04-15 | 2017-03-31 | Байер Интеллекчуал Проперти Гмбх | Очень низкодозированные твердые пероральные лекарственные формы для гормонозаместительной терапии (гзт) |
US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
CN102516247A (zh) * | 2010-12-15 | 2012-06-27 | 连云港金康医药科技有限公司 | A型l-5-甲基四氢叶酸钙盐多晶型及其制备方法 |
EP2383279A1 (fr) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Procédé de préparation d'estetrol |
EP2781214A1 (fr) * | 2013-03-22 | 2014-09-24 | Chemo Research, S.L. | Formulation de calcium amorphe L-5-méthyltétrahydrofolate (L-5-MTHF-Ca) |
EP2878600B1 (fr) | 2013-12-02 | 2018-06-27 | Cerbios-Pharma S.A. | Complexes stables d'un sel de métal alcalino-terreux d'acide N5-méthyl-tétrahydrofolique et un polyol |
CN104490887A (zh) * | 2014-09-04 | 2015-04-08 | 连云港金康和信药业有限公司 | (6s)-5-甲基-四氢叶酸钙盐的稳定药物组合物 |
ME03728B (fr) | 2015-06-18 | 2021-01-20 | Estetra Sprl | Unité galénique orodispersible contenant un composant estetrol |
RS61777B1 (sr) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Oralno-disperzibilna tableta koja sadrži estetrol |
SI3310345T1 (sl) | 2015-06-18 | 2021-05-31 | Estetra Sprl | Orodisperzibilna tableta, ki vsebuje estetrol |
MY195019A (en) | 2015-06-18 | 2023-01-03 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
CN105030779A (zh) * | 2015-07-21 | 2015-11-11 | 福格森(武汉)生物科技股份有限公司 | 一种(6s)-5-甲基四氢叶酸钙口服营养补充剂及其制备方法 |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
CN106336444A (zh) * | 2016-08-23 | 2017-01-18 | 国家卫生计生委科学技术研究所 | 一种新晶型炔雌醇 |
CN107446458A (zh) * | 2017-08-04 | 2017-12-08 | 合众(佛山)化工有限公司 | 一种高耐水性的丙烯酸改性聚氨酯杂化树脂水性涂料 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
CN110237046B (zh) * | 2019-03-29 | 2021-07-30 | 福格森(武汉)生物科技股份有限公司 | 一种l-5-甲基四氢叶酸微囊的制备方法 |
CN110548034A (zh) * | 2019-07-12 | 2019-12-10 | 广州莎蔓生物科技有限公司 | 一种怀孕阻断药物 |
CN114569567B (zh) * | 2021-12-20 | 2023-03-14 | 南通联亚药业股份有限公司 | 一种稳定的双醋炔诺酮炔雌醇复方片及其制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3347125A1 (de) | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption |
FR2676927B1 (fr) * | 1991-05-29 | 1995-06-23 | Ibf | Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant. |
TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
DE4426709A1 (de) | 1994-07-20 | 1996-01-25 | Schering Ag | Steroidale Sexualhormone enthaltende feste Arzneiformen |
US5916593A (en) * | 1994-09-22 | 1999-06-29 | Akzo Nobel, N.V. | Process of making dosage units by wet granulation |
RU2073529C1 (ru) * | 1995-05-16 | 1997-02-20 | Центральный научно-исследовательский рентгенорадиологический институт | Композиция для эмболизации кровеносных сосудов |
CH693255A5 (de) | 1997-06-13 | 2003-05-15 | Eprova Ag | Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels. |
EP2002839A1 (fr) | 1998-04-17 | 2008-12-17 | Ortho McNeil Pharmaceutical, Inc. | Compositions pharmaceutiques contenant un acide folique, et procédés associés et systèmes de livraison |
US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
CH693905A5 (de) | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
MXPA02002043A (es) * | 1999-08-31 | 2003-08-20 | Schering Ag | Composicion farmaceutica de etinilestradiol y drospirenona para el uso como anticonceptivo. |
EP1380301B1 (fr) * | 1999-08-31 | 2009-01-14 | Bayer Schering Pharma Aktiengesellschaft | Combinaison pharmaceutique d'éthinylestradiol et de drospirénone comme contraceptif |
DE60113809T2 (de) | 2000-01-18 | 2006-06-22 | Schering Ag | Pharmazeutische kombination aus mikronisiertem drospirenon und einen estrogen für die hormonersatztherapie |
US6550482B1 (en) * | 2000-04-21 | 2003-04-22 | Vascular Control Systems, Inc. | Methods for non-permanent occlusion of a uterine artery |
US6864774B2 (en) | 2000-10-19 | 2005-03-08 | Matsushita Electric Industrial Co., Ltd. | Inductance component and method of manufacturing the same |
EP1216713A1 (fr) | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Compositions de complexes de estrogen-cyclodextrine |
EP1216712A1 (fr) | 2000-12-20 | 2002-06-26 | Schering Aktiengesellschaft | Complexes d'inclusion de drospirenone et de cyclodextrines |
US6537569B2 (en) * | 2001-02-14 | 2003-03-25 | Microvention, Inc. | Radiation cross-linked hydrogels |
PL209558B1 (pl) * | 2002-02-21 | 2011-09-30 | Bayer Schering Pharma Ag | Zestaw zawierający steroid, składnik tetrahydrofolianowy i witaminę B12 do zastosowania w metodzie hormonalnej antykoncepcji lub hormonalnej terapii zastępczej |
WO2004039425A1 (fr) * | 2002-10-29 | 2004-05-13 | Toray Industries, Inc. | Materiau d'embolisation vasculaire |
UY29527A1 (es) * | 2005-05-13 | 2006-12-29 | Schering Ag | Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato. |
CN101489563A (zh) | 2006-07-06 | 2009-07-22 | 拜耳先灵医药股份有限公司 | 用于避孕和预防先天性畸形风险的药物制剂 |
JP2009542588A (ja) * | 2006-07-06 | 2009-12-03 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | 避妊及び先天的異常の危険性の予防のための医薬製剤 |
RU62008U1 (ru) * | 2006-10-13 | 2007-03-27 | Закрытое акционерное общество "ААА-КОМПАНИ" | Средство для эмболизации сосудов |
RU61120U1 (ru) * | 2006-10-13 | 2007-02-27 | Закрытое акционерное общество "ААА-КОМПАНИ" | Средство для эмболизации сосудов |
US8916188B2 (en) * | 2008-04-18 | 2014-12-23 | Abbott Cardiovascular Systems Inc. | Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block |
-
2007
- 2007-05-05 CN CNA2007800254913A patent/CN101489563A/zh active Pending
- 2007-06-21 MY MYPI20070991A patent/MY169516A/en unknown
- 2007-06-25 TW TW096122889A patent/TWI508730B/zh active
- 2007-06-25 TW TW104122823A patent/TW201538161A/zh unknown
- 2007-06-29 NZ NZ573766A patent/NZ573766A/en unknown
- 2007-06-29 CN CN201210143925.2A patent/CN102813663B/zh active Active
- 2007-06-29 BR BRPI0713565A patent/BRPI0713565B8/pt active IP Right Grant
- 2007-06-29 EP EP11190550.1A patent/EP2422774B1/fr not_active Revoked
- 2007-06-29 CA CA2656131A patent/CA2656131C/fr not_active Expired - Fee Related
- 2007-06-29 AU AU2007271449A patent/AU2007271449B2/en active Active
- 2007-06-29 WO PCT/EP2007/005764 patent/WO2008003432A1/fr active Application Filing
- 2007-06-29 UA UAA201207425A patent/UA105078C2/uk unknown
- 2007-06-29 CA CA2856344A patent/CA2856344C/fr not_active Expired - Fee Related
- 2007-06-29 KR KR1020097002386A patent/KR20090033889A/ko not_active Application Discontinuation
- 2007-06-29 JP JP2009517003A patent/JP2009542591A/ja active Pending
- 2007-06-29 UA UAA200900637A patent/UA100228C2/uk unknown
- 2007-06-29 KR KR1020137006954A patent/KR20130042638A/ko not_active Application Discontinuation
- 2007-06-29 NO NO20090578A patent/NO347567B1/no unknown
- 2007-06-29 EP EP07764936.6A patent/EP2040683B2/fr active Active
- 2007-06-29 CN CN2007800255704A patent/CN101484143B/zh active Active
- 2007-06-29 ES ES07764936T patent/ES2626838T5/es active Active
- 2007-06-29 SG SG2013017165A patent/SG188869A1/en unknown
- 2007-06-29 RU RU2009103649/15A patent/RU2479306C2/ru active
- 2007-06-29 MX MX2009000079A patent/MX2009000079A/es active IP Right Grant
- 2007-07-04 UY UY30462A patent/UY30462A1/es not_active Application Discontinuation
- 2007-07-05 PE PE2014002543A patent/PE20150287A1/es active IP Right Grant
- 2007-07-05 PE PE2011002146A patent/PE20120375A1/es active IP Right Grant
- 2007-07-05 CL CL2007001962A patent/CL2007001962A1/es unknown
- 2007-07-05 PE PE2007000867A patent/PE20080273A1/es not_active Application Discontinuation
- 2007-07-06 AR ARP070103016A patent/AR061958A1/es not_active Application Discontinuation
-
2008
- 2008-12-18 IL IL196027A patent/IL196027A0/en active IP Right Grant
- 2008-12-31 TN TNP2008000543A patent/TNSN08543A1/en unknown
-
2009
- 2009-01-05 EC EC2009009030A patent/ECSP099030A/es unknown
- 2009-01-06 CR CR10549A patent/CR10549A/es not_active Application Discontinuation
- 2009-01-06 CU CU2009000004A patent/CU20090004A7/es active IP Right Grant
- 2009-01-06 CO CO09000752A patent/CO6150125A2/es unknown
- 2009-01-06 GT GT200900001A patent/GT200900001A/es unknown
- 2009-01-23 MA MA31584A patent/MA30598B1/fr unknown
- 2009-02-05 ZA ZA2009/00868A patent/ZA200900868B/en unknown
- 2009-12-17 HK HK09111877.6A patent/HK1131917A1/xx unknown
-
2012
- 2012-08-02 RU RU2012133154A patent/RU2624236C2/ru active
- 2012-09-06 PH PH12012501774A patent/PH12012501774B1/en unknown
-
2013
- 2013-01-30 IL IL224484A patent/IL224484A/en active IP Right Grant
-
2015
- 2015-03-11 ZA ZA2015/01673A patent/ZA201501673B/en unknown
-
2016
- 2016-04-21 IL IL245355A patent/IL245355B/en active IP Right Grant
- 2016-11-03 AR ARP160103347A patent/AR106561A2/es not_active Application Discontinuation
-
2018
- 2018-11-29 ZA ZA2018/08084A patent/ZA201808084B/en unknown
- 2018-11-29 ZA ZA2018/08083A patent/ZA201808083B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30598B1 (fr) | Composition pharmaceutique contenant un acide tetrahydrofolique. | |
MA27729A1 (fr) | Compositions pharmaceutiques solides contenant un agoniste des recepteurs de la s1p et un alcool de sucre | |
PL1750862T3 (pl) | Kompozycja farmaceutyczna zawierająca irbesartan | |
EA200600884A1 (ru) | Композиции комплексов экстроген-циклодекстрин | |
BRPI0511036A (pt) | formulações de solução farmacêuticas contendo 17-aag | |
EA018193B3 (ru) | Соединения и фармацевтические композиции для снижения уровня мочевой кислоты | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
MX2007012947A (es) | Composiciones biomejoradas. | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
GEP20125628B (en) | Pharmaceutical compositions containing antagonist anti-cd40 antibody | |
EE05533B1 (et) | Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja strogeeni ning nende kasutamine | |
PL2168585T3 (pl) | Kompozycje farmaceutyczne steroidów neuroaktywnych i ich zastosowania | |
MA30478B1 (fr) | Composition comprenant au moins un alcool aliphatique superieur et un extrait de griffonia simplicifolia. | |
MA30672B1 (fr) | Utilisation de derives de l'azabicyclo hexane | |
CA2521909A1 (fr) | Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee | |
MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
MA31142B1 (fr) | Derives heteroaryles de pyrrolidinyl et piperdinyl cetones. | |
MY129668A (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
TW200621773A (en) | Bicyclononene derivatives | |
EE200100104A (et) | 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm | |
MXPA06000226A (es) | Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo[3.3..0]-octano-3-carboxilico. | |
MA33602B1 (fr) | Composition pharmaceutique permettant de prévenir ou de traiter l'arthrite rhumatoïde, contenant du rébamipide | |
MXPA05011497A (es) | Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace). | |
MA30691B1 (fr) | Compositions pharmaceutiques contenant un anticorps monoclonal anti-idiotypique anti-ca-125 et de l'aluminium. |